May 18: Apeptico completes €3.4m financing round
May 16: GSK acquires Cellzome 100%
May 15: Reel change after change of scene
May 14: Co-stimulators of drug-trial disaster identified
May 11: EP says no to patents on breeding
May 10: GSK makes hostile $2.6bn for Human Genome Sciences
May 09: Intercell in a €25m finance deal with BB Biotech
May 08: Money pouring into Nanopore
May 07: NICE and IQWiG nix Benlysta
May 04: Iteos raises €9m in Series A
May 03: Novo Nordisk bags drug delivery platform for $100m
May 02: Avastin less safe than Lucentis as AMD therapy
Apr 30: Genzyme boosts Sanofi earnings
Apr 27: Spanish Zeltia bags milestone payment
Apr 26: EU approves Signifor from Novartis
Apr 25: BiTE antibodies: Bayer does it again
Apr 25: Hell-bent on a kidney drug
Apr 23: EMA limits use for MS pill Gilenya
Apr 20: GSK bids for Human Genome Science
Apr 19: Receptor transplant makes blind mice see
Apr 18: UCB: Positive phase III results
Apr 04: AstraZeneca is looking to partner with peers
Apr 03: UK alliance on ninja antibodies
Apr 02: UK Biobank data available to researchers
Mar 30: Atlas of cancer cell drug sensitivity launched
Mar 29: Promethera Biosciences bags €23.6m.
Mar 28: Bioamber produces bio-based 1,4-butanediol on industrial scale
Mar 27: Hail the antibody, cure with ease
Mar 26: Roche runs for EU application of subcutaneous Herceptin
Mar 23: EU to limit use of health claims
